These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 16625585

  • 1. Anti-IgE for chronic asthma in adults and children.
    Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.
    Cochrane Database Syst Rev; 2006 Apr 19; (2):CD003559. PubMed ID: 16625585
    [Abstract] [Full Text] [Related]

  • 2. Anti-IgE for chronic asthma in adults and children.
    Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.
    Cochrane Database Syst Rev; 2004 Apr 19; (3):CD003559. PubMed ID: 15266491
    [Abstract] [Full Text] [Related]

  • 3. Omalizumab for asthma in adults and children.
    Normansell R, Walker S, Milan SJ, Walters EH, Nair P.
    Cochrane Database Syst Rev; 2014 Jan 13; 2014(1):CD003559. PubMed ID: 24414989
    [Abstract] [Full Text] [Related]

  • 4. Anti-IgE for chronic asthma.
    Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.
    Cochrane Database Syst Rev; 2003 Jan 13; (3):CD003559. PubMed ID: 12917972
    [Abstract] [Full Text] [Related]

  • 5. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
    Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.
    Pediatrics; 2001 Aug 13; 108(2):E36. PubMed ID: 11483846
    [Abstract] [Full Text] [Related]

  • 6. Spotlight on omalizumab in allergic asthma.
    Bang LM, Plosker GL.
    BioDrugs; 2004 Aug 13; 18(6):415-8. PubMed ID: 15571425
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
    Lanier B, Bridges T, Kulus M, Taylor AF, Berhane I, Vidaurre CF.
    J Allergy Clin Immunol; 2009 Dec 13; 124(6):1210-6. PubMed ID: 19910033
    [Abstract] [Full Text] [Related]

  • 9. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.
    Norman G, Faria R, Paton F, Llewellyn A, Fox D, Palmer S, Clifton I, Paton J, Woolacott N, McKenna C.
    Health Technol Assess; 2013 Nov 13; 17(52):1-342. PubMed ID: 24267198
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L, Sorkness CA.
    Ann Pharmacother; 2007 Sep 13; 41(9):1397-410. PubMed ID: 17698897
    [Abstract] [Full Text] [Related]

  • 12. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
    D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G.
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov 13; 1(3):225-31. PubMed ID: 19075985
    [Abstract] [Full Text] [Related]

  • 13. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.
    Chipps BE, Figliomeni M, Spector S.
    Allergy Asthma Proc; 2012 Nov 13; 33(5):377-85. PubMed ID: 23026179
    [Abstract] [Full Text] [Related]

  • 14. Anti-IgE and chemotherapy: a critical appraisal of treatment options for severe asthma.
    Walters EH, Walters JA, Wood-Baker R.
    Expert Opin Pharmacother; 2007 Apr 13; 8(5):585-92. PubMed ID: 17376014
    [Abstract] [Full Text] [Related]

  • 15. Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma.
    Kulus M, Hébert J, Garcia E, Fowler Taylor A, Fernandez Vidaurre C, Blogg M.
    Curr Med Res Opin; 2010 Jun 13; 26(6):1285-93. PubMed ID: 20377320
    [Abstract] [Full Text] [Related]

  • 16. Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.
    Hanania NA, Alpan O, Hamilos DL, Condemi JJ, Reyes-Rivera I, Zhu J, Rosen KE, Eisner MD, Wong DA, Busse W.
    Ann Intern Med; 2011 May 03; 154(9):573-82. PubMed ID: 21536936
    [Abstract] [Full Text] [Related]

  • 17. [Anti IgE antibodies for the treatment of difficult asthma].
    Humbert M, Tonnel AB.
    Rev Mal Respir; 2005 Dec 03; 22(6 Pt 1):983-90. PubMed ID: 16222222
    [Abstract] [Full Text] [Related]

  • 18. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Ducharme FM, Lasserson TJ, Cates CJ.
    Cochrane Database Syst Rev; 2011 May 11; (5):CD003137. PubMed ID: 21563136
    [Abstract] [Full Text] [Related]

  • 19. The role of omalizumab in the treatment of severe allergic asthma.
    Chapman KR, Cartier A, Hébert J, McIvor RA, Schellenberg RR.
    Can Respir J; 2006 May 11; 13 Suppl B(Suppl B):1B-9B. PubMed ID: 16909166
    [Abstract] [Full Text] [Related]

  • 20. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
    D'Amato G, Liccardi G, Noschese P, Salzillo A, D'Amato M, Cazzola M.
    Curr Drug Targets Inflamm Allergy; 2004 Sep 11; 3(3):227-9. PubMed ID: 15379589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.